Kavigale TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: sipavibart
Pack: Kavigale 300 mg/2 mL injection, 2 mL vial
Brand name
(ARTG)
: KAVIGALE, sipavibart, 300 mg in 2 mL (150 mg/mL), Solution for injection/infusion vial.What this medicine is used for
(ARTG)
KAVIGALE is indicated for the pre-exposure prophylaxis of COVID 19 in adults and adolescents aged 12 years and older weighing at least 40 kg who are immunocompromised due to a medical condition or receipt of immunosuppressive medications or treatments. KAVIGALE is not recommended as a substitute for vaccination in individuals for whom COVID-19 vaccination is recommended.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, solution
- Intravenous Infusion
- Clear to opalescent, colourless to slightly yellow solution.
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Store in Original Container
- Do not Shake
- Shelf lifetime is 24 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- Each pack contains 1 vial. pack
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
